(Q42442848)

31 October 2017

title

Activation loop tyrosines allow the JAK2(V617F) mutant to attain hyperactivation (English)

1 reference

31 October 2017

Kanakadurga Kundrapu

1

1 reference

31 October 2017

Latoya Colenberg

series ordinal

2

1 reference

31 October 2017

Roy J Duhé

series ordinal

3

1 reference

31 October 2017

publication date

1 January 2008

1 reference

Cell Biochemistry and Biophysics

31 October 2017

published in

1 reference

31 October 2017

volume

52

1 reference

31 October 2017

issue

2

1 reference

31 October 2017

page(s)

103-112

1 reference

https://scigraph.springernature.com/pub.10.1007/s12013-008-9025-4

31 October 2017

exact match

0 references

cites work

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1007%2FS12013-008-9025-4

Crossref

reference URL

A unique activating mutation in JAK2 (V617F) is at the origin of polycythemia vera and allows a new classification of myeloproliferative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-008-9025-4

Crossref

reference URL

Activation of Jak2 catalytic activity requires phosphorylation of Y1007 in the kinase activation loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-008-9025-4

Crossref

reference URL

10.1007/S12013-008-9025-4

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

31 October 2017

1020517213

0 references

1 reference